Business Context and Reporting Period
Company: SPACEHAB, Incorporated (Note: Input metadata referenced "ASTROTECH Corp," but the filing text identifies the registrant as SPACEHAB, Inc., with Astrotech as a subsidiary).
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008
Business Overview: SPACEHAB provides spacecraft pre-launch processing facilities, payload processing services, and engineering solutions. Operations are divided into three segments: Astrotech Space Operations (commercial and government launch processing), Astrotech Engineering Services (government engineering support), and SPACEHAB Flight Services (formerly focused on space shuttle modules, now with no scheduled missions).
Key Financial Metrics
| Metric | Q1 FY2009 (Sep 30, 2008) | Q1 FY2008 (Sep 30, 2007) |
|---|---|---|
| Revenue | $5.97 million | $8.60 million |
| Gross Profit | $2.46 million | $2.16 million |
| Net Income (Loss) | $0.06 million | $(0.86) million |
| Diluted EPS | $0.00 | $(0.66) |
| Cash & Cash Equivalents | $2.50 million | $2.56 million |
| Restricted Cash | $10.58 million | $8.39 million |
| Total Debt (Current + Non-Current) | $11.58 million | $63.40 million |
| Working Capital | $2.16 million | $(1.00) million (approx.) |
Note: Total debt decreased significantly due to the conversion and redemption of convertible notes in the prior year.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 30.2% to $5.97 million. This was driven by a 100% drop in Flight Services revenue (due to the end of space shuttle module missions) and a 92.3% drop in Engineering Services revenue (due to the termination of the NASA PI&C subcontract in June 2008).
- Astrotech Growth: Astrotech Space Operations revenue increased 54.1% to $5.70 million, becoming 96% of total revenue. Growth was driven by increased mission processing at Vandenberg Air Force Base and Sea Launch support.
- Profitability Improvement: The company returned to profitability with a net income of $55,000, compared to a net loss of $856,000 in the prior year. This was primarily due to a significant reduction in interest expense ($223k vs $1.07M) following the conversion of senior and junior convertible notes in late 2007.
- Cash Flow: Net cash used in operating activities improved significantly to $(0.90) million from $(6.96) million in the prior year, aided by higher net income and lower restricted cash increases.
Guidance, Outlook, and Risks
- Liquidity Position: Management states it has sufficient liquidity and backlog to fund operations for at least the next fiscal year. Total cash and restricted cash stood at $13.1 million. A $4.0 million term loan and $2.0 million revolving credit facility were secured in February 2008.
- New Business Initiatives: The company is investing in BioSpace Technologies (space-based life sciences) and SPACETECH (commercialization of space technologies like the 1st Detect spectrometer and AirWard containers). No revenue has been recorded from these initiatives as of September 30, 2008.
- Construction Contingency: A $34.2 million facility modification contract at Vandenberg carries a potential penalty contingency of up to $3.0 million if the September 30, 2009 completion date is missed.
- Legal & Regulatory: The company faced a NASDAQ delisting notice in October 2008 for failing to maintain a $1.00 bid price. However, NASDAQ suspended the rule until January 2009, temporarily resolving the compliance issue. An appeal hearing was scheduled for November 2008.
- Subsequent Events: On October 31, 2008, the company repurchased $1.75 million of its 5.5% convertible notes for $1.085 million, recognizing a gain of $665,000.
Investor Verification Checklist
- Revenue Concentration: Verify the sustainability of Astrotech Space Operations, which now accounts for 96% of revenue, following the loss of NASA Flight Services and Engineering contracts.
- Construction Contract Risks: Assess the likelihood of meeting the September 2009 deadline for the Vandenberg facility modification to avoid the $3.0 million penalty.
- Stock Price Compliance: Monitor the company's ability to maintain the $1.00 minimum bid price required by NASDAQ to avoid future delisting.
- Debt Covenants: Review compliance with the new bank financing covenants (minimum tangible net worth, cash flow coverage) given the company's historical volatility.
- New Venture Viability: Evaluate the timeline and capital requirements for the BioSpace and SPACETECH initiatives to generate revenue.